Linda P. Briley
Linda P. Briley publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations and HER2/EGFR in Cancer Research.
- World rank
- #2,165,480 of 7,710,434 ranked researchers
- Rank in United States
- #651,161 of 1,627,098
- Works
- 32
- Citations
- 1.2k
- Citations per work
- 39.0
What does Linda P. Briley research?
Linda P. Briley's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (36%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1238.1%
- Medicine1238.1%
- Life Sciences1135.8%
- Everything else826.1%
- 1Molecular Biology26% of their works
- 2Oncology18% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Genetics8% of their works
- 5Cancer Research5% of their works
- 6Genetics5% of their works
Research topics
Which keywords describe Linda P. Briley's research?
The keywords of their largest research topics: Chemotherapy, DNA Damage, Chronic Lymphocytic Leukemia, EGFR Mutations, Genomic Aberrations, Targeted Therapy, Breast Cancer and HER2.
- MAP Kinase
- Genome-Wide Association
- Cetuximab
- Repair
- Genomic Instability
- HER2
- Targeted Therapy
- EGFR Mutations
- DNA Damage
- Chemotherapy
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Breast Cancer
- Comet Assay
- Genotoxicity Testing
- BRAF gene
- Genetic Variation
- KRAS Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Chemotherapy92 topics
- DNA Damage82 topics
- Chronic Lymphocytic Leukemia71 topic
- EGFR Mutations71 topic
- Genomic Aberrations71 topic
- Targeted Therapy71 topic
- Breast Cancer61 topic
- HER261 topic
- Comet Assay41 topic
- Genomic Instability41 topic
- Genotoxicity Testing41 topic
- Repair41 topic
- BRAF gene31 topic
- Cetuximab31 topic
- Genetic Variation31 topic
- Genome-Wide Association31 topic
- KRAS Mutations31 topic
- MAP Kinase31 topic
Where does Linda P. Briley work?
Linda P. Briley's main affiliation in the publication record is GlaxoSmithKline (United States), United States.
How many publications and citations does Linda P. Briley have?
OpenAlex counts 32 works and 1,248 citations for Linda P. Briley, an h-index of 12, ranking #2,165,480 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Linda P. Briley. Posts are plain text and can be reported.